Status:
COMPLETED
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)
Lead Sponsor:
Genentech, Inc.
Conditions:
Psoriasis
Pregnancy
Eligibility:
FEMALE
Brief Summary
The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.
Eligibility Criteria
Inclusion
- Any patient who has used Raptiva within 6 weeks prior to conception or during her pregnancy may be included in the Registry. Enrollment is based on Raptiva exposure, whether inadvertent or deliberate, in relation to pregnancy. Enrollment should occur as early as possible during the pregnancy and must occur prior to knowledge of pregnancy outcome.
Exclusion
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00097240
Start Date
January 1 2005
End Date
September 1 2009
Last Update
August 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FOLLOW Raptiva Pregnancy Registry
Morrisville, North Carolina, United States, 27560